Viviant (bazedoxifene)
By Business Review Editor
Pharma Deals Review: Vol 2007 Issue 86 (Table of Contents)
Published: 7 Aug-2007
DOI: 10.3833/pdr.v2007.i86.300 ISSN: 1756-7874
Section: Deal Trackers
Fulltext:
Abstract
Bazedoxifene is a third-generation selective oestrogen receptor modulator (SERM), which originated with Ligand Pharmaceuticals as TSE-424, a treatment for postmenopausal osteoporosis (PMO), and has been developed in an alliance which began in September 1994 with Wyeth-Ayerst Laboratories, of American Home Products (AHP)...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
Login Problems
RSS